TAK

#477
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
17.8500 USD
+0.08%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
17.8500
17.8500
Rango anual
12.9900
18.8950
Cambio diario
+0.08%
Variación mensual
-1.44%
Variación en los últimos 6 meses
+25.84%
Cambio anual
+25.84%
Cierres anteriores
17.8350
Abrir
17.8500
Bid
Ask
Mínimo
17.8500
High
17.8500
Volumen
1
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 20202021202220232024 TTM

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Noticias